COVID-19 Impact on Global Biologicals for Systemic Lupus Erythematosus Market Size, Status and Forecast 2020-2026

July 2020 | 90 pages | ID: C08EFBAF4060EN
QYResearch

Abstracts

This report focuses on the global Biologicals for Systemic Lupus Erythematosus status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologicals for Systemic Lupus Erythematosus development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Roche
• GlaxoSmithKline
• Shanghai Junshi Biosciences
• ACEA Biosciences

Market segment by Type, the product can be split into

• Rituximab
• Belimumab
• Anifrolumab
• UBP-1213
• Other

Market segment by Application, split into

• Hospital
• Clinic
• Pharmacy
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Biologicals for Systemic Lupus Erythematosus status, future forecast, growth opportunity, key market and key players.
• To present the Biologicals for Systemic Lupus Erythematosus development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biologicals for Systemic Lupus Erythematosus are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologicals for Systemic Lupus Erythematosus Revenue
1.4 Market Analysis by Type
  1.4.1 Global Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rituximab
  1.4.3 Belimumab
  1.4.4 Anifrolumab
  1.4.5 UBP-1213
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Biologicals for Systemic Lupus Erythematosus Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Pharmacy
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biologicals for Systemic Lupus Erythematosus Industry Impact
  1.6.1 How the Covid-19 is Affecting the Biologicals for Systemic Lupus Erythematosus Industry
    1.6.1.1 Biologicals for Systemic Lupus Erythematosus Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Biologicals for Systemic Lupus Erythematosus Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Biologicals for Systemic Lupus Erythematosus Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Biologicals for Systemic Lupus Erythematosus Market Perspective (2015-2026)
2.2 Biologicals for Systemic Lupus Erythematosus Growth Trends by Regions
  2.2.1 Biologicals for Systemic Lupus Erythematosus Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Biologicals for Systemic Lupus Erythematosus Historic Market Share by Regions (2015-2020)
  2.2.3 Biologicals for Systemic Lupus Erythematosus Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Biologicals for Systemic Lupus Erythematosus Market Growth Strategy
  2.3.6 Primary Interviews with Key Biologicals for Systemic Lupus Erythematosus Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Biologicals for Systemic Lupus Erythematosus Players by Market Size
  3.1.1 Global Top Biologicals for Systemic Lupus Erythematosus Players by Revenue (2015-2020)
  3.1.2 Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Players (2015-2020)
  3.1.3 Global Biologicals for Systemic Lupus Erythematosus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologicals for Systemic Lupus Erythematosus Market Concentration Ratio
  3.2.1 Global Biologicals for Systemic Lupus Erythematosus Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Biologicals for Systemic Lupus Erythematosus Revenue in 2019
3.3 Biologicals for Systemic Lupus Erythematosus Key Players Head office and Area Served
3.4 Key Players Biologicals for Systemic Lupus Erythematosus Product Solution and Service
3.5 Date of Enter into Biologicals for Systemic Lupus Erythematosus Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Biologicals for Systemic Lupus Erythematosus Historic Market Size by Type (2015-2020)
4.2 Global Biologicals for Systemic Lupus Erythematosus Forecasted Market Size by Type (2021-2026)

5 BIOLOGICALS FOR SYSTEMIC LUPUS ERYTHEMATOSUS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)
5.2 Global Biologicals for Systemic Lupus Erythematosus Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
6.2 Biologicals for Systemic Lupus Erythematosus Key Players in North America (2019-2020)
6.3 North America Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
6.4 North America Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
7.2 Biologicals for Systemic Lupus Erythematosus Key Players in Europe (2019-2020)
7.3 Europe Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
7.4 Europe Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

8 CHINA

8.1 China Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
8.2 Biologicals for Systemic Lupus Erythematosus Key Players in China (2019-2020)
8.3 China Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
8.4 China Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
9.2 Biologicals for Systemic Lupus Erythematosus Key Players in Japan (2019-2020)
9.3 Japan Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
9.4 Japan Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
10.2 Biologicals for Systemic Lupus Erythematosus Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
10.4 Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

11 INDIA

11.1 India Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
11.2 Biologicals for Systemic Lupus Erythematosus Key Players in India (2019-2020)
11.3 India Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
11.4 India Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Biologicals for Systemic Lupus Erythematosus Market Size (2015-2020)
12.2 Biologicals for Systemic Lupus Erythematosus Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020)
12.4 Central & South America Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Biologicals for Systemic Lupus Erythematosus Introduction
  13.1.4 Roche Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Introduction
  13.2.4 GlaxoSmithKline Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Shanghai Junshi Biosciences
  13.3.1 Shanghai Junshi Biosciences Company Details
  13.3.2 Shanghai Junshi Biosciences Business Overview and Its Total Revenue
  13.3.3 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Introduction
  13.3.4 Shanghai Junshi Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
  13.3.5 Shanghai Junshi Biosciences Recent Development
13.4 ACEA Biosciences
  13.4.1 ACEA Biosciences Company Details
  13.4.2 ACEA Biosciences Business Overview and Its Total Revenue
  13.4.3 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Introduction
  13.4.4 ACEA Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
  13.4.5 ACEA Biosciences Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Biologicals for Systemic Lupus Erythematosus Key Market Segments
Table 2. Key Players Covered: Ranking by Biologicals for Systemic Lupus Erythematosus Revenue
Table 3. Ranking of Global Top Biologicals for Systemic Lupus Erythematosus Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rituximab
Table 6. Key Players of Belimumab
Table 7. Key Players of Anifrolumab
Table 8. Key Players of UBP-1213
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Biologicals for Systemic Lupus Erythematosus Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Biologicals for Systemic Lupus Erythematosus Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Biologicals for Systemic Lupus Erythematosus Players to Combat Covid-19 Impact
Table 15. Global Biologicals for Systemic Lupus Erythematosus Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Biologicals for Systemic Lupus Erythematosus Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Biologicals for Systemic Lupus Erythematosus Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Biologicals for Systemic Lupus Erythematosus Market Share by Regions (2015-2020)
Table 19. Global Biologicals for Systemic Lupus Erythematosus Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Biologicals for Systemic Lupus Erythematosus Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Biologicals for Systemic Lupus Erythematosus Market Growth Strategy
Table 25. Main Points Interviewed from Key Biologicals for Systemic Lupus Erythematosus Players
Table 26. Global Biologicals for Systemic Lupus Erythematosus Revenue by Players (2015-2020) (Million US$)
Table 27. Global Biologicals for Systemic Lupus Erythematosus Market Share by Players (2015-2020)
Table 28. Global Top Biologicals for Systemic Lupus Erythematosus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologicals for Systemic Lupus Erythematosus as of 2019)
Table 29. Global Biologicals for Systemic Lupus Erythematosus by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Biologicals for Systemic Lupus Erythematosus Product Solution and Service
Table 32. Date of Enter into Biologicals for Systemic Lupus Erythematosus Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 35. Global Biologicals for Systemic Lupus Erythematosus Market Size Share by Type (2015-2020)
Table 36. Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Type (2021-2026)
Table 37. Global Biologicals for Systemic Lupus Erythematosus Market Size Share by Application (2015-2020)
Table 38. Global Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 39. Global Biologicals for Systemic Lupus Erythematosus Market Size Share by Application (2021-2026)
Table 40. North America Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 42. North America Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 43. North America Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 44. North America Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 45. North America Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 46. Europe Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 48. Europe Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 50. Europe Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 52. China Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 53. China Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 54. China Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 55. China Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 56. China Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 57. China Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 58. Japan Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 60. Japan Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 62. Japan Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 66. Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 68. Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 70. India Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 71. India Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 72. India Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 73. India Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 74. India Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 75. India Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Biologicals for Systemic Lupus Erythematosus Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Biologicals for Systemic Lupus Erythematosus Market Share (2019-2020)
Table 78. Central & South America Biologicals for Systemic Lupus Erythematosus Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Biologicals for Systemic Lupus Erythematosus Market Share by Type (2015-2020)
Table 80. Central & South America Biologicals for Systemic Lupus Erythematosus Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Biologicals for Systemic Lupus Erythematosus Market Share by Application (2015-2020)
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. Shanghai Junshi Biosciences Company Details
Table 93. Shanghai Junshi Biosciences Business Overview
Table 94. Shanghai Junshi Biosciences Product
Table 95. Shanghai Junshi Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020) (Million US$)
Table 96. Shanghai Junshi Biosciences Recent Development
Table 97. ACEA Biosciences Company Details
Table 98. ACEA Biosciences Business Overview
Table 99. ACEA Biosciences Product
Table 100. ACEA Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2015-2020) (Million US$)
Table 101. ACEA Biosciences Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Biologicals for Systemic Lupus Erythematosus Market Share by Type: 2020 VS 2026
Figure 2. Rituximab Features
Figure 3. Belimumab Features
Figure 4. Anifrolumab Features
Figure 5. UBP-1213 Features
Figure 6. Other Features
Figure 7. Global Biologicals for Systemic Lupus Erythematosus Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Biologicals for Systemic Lupus Erythematosus Report Years Considered
Figure 13. Global Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Biologicals for Systemic Lupus Erythematosus Market Share by Regions: 2020 VS 2026
Figure 15. Global Biologicals for Systemic Lupus Erythematosus Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Biologicals for Systemic Lupus Erythematosus Market Share by Players in 2019
Figure 18. Global Top Biologicals for Systemic Lupus Erythematosus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologicals for Systemic Lupus Erythematosus as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Biologicals for Systemic Lupus Erythematosus Revenue in 2019
Figure 20. North America Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
Figure 29. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GlaxoSmithKline Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
Figure 31. Shanghai Junshi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Shanghai Junshi Biosciences Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
Figure 33. ACEA Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ACEA Biosciences Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed